Tuesday, April 2, 2019

Cadila Healthcare gains on USFDA's tentative approval to market a drug

Zydus Cadila has received the tentative approval from the USFDA to market Mirabegron Extended-Release Tablets.

from Moneycontrol https://ift.tt/2FILveN

No comments:

Post a Comment

Trading Books